JP2020532513A5 - - Google Patents

Download PDF

Info

Publication number
JP2020532513A5
JP2020532513A5 JP2020511759A JP2020511759A JP2020532513A5 JP 2020532513 A5 JP2020532513 A5 JP 2020532513A5 JP 2020511759 A JP2020511759 A JP 2020511759A JP 2020511759 A JP2020511759 A JP 2020511759A JP 2020532513 A5 JP2020532513 A5 JP 2020532513A5
Authority
JP
Japan
Prior art keywords
compound
solvents
triaminopyrimidine
acid
reacting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2020511759A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020532513A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2018/056732 external-priority patent/WO2019049021A1/en
Publication of JP2020532513A publication Critical patent/JP2020532513A/ja
Publication of JP2020532513A5 publication Critical patent/JP2020532513A5/ja
Withdrawn legal-status Critical Current

Links

JP2020511759A 2017-09-05 2018-09-04 トリアミノピリミジン化合物およびその中間体の調製方法 Withdrawn JP2020532513A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN201721031453 2017-09-05
IN201721031453 2017-09-05
IN201721034342 2017-09-27
IN201721034342 2017-09-27
PCT/IB2018/056732 WO2019049021A1 (en) 2017-09-05 2018-09-04 PROCESS FOR THE PREPARATION OF TRIAMINOPYRIMIDINE COMPOUND AND ITS INTERMEDIATES

Publications (2)

Publication Number Publication Date
JP2020532513A JP2020532513A (ja) 2020-11-12
JP2020532513A5 true JP2020532513A5 (enExample) 2021-09-30

Family

ID=63684213

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020511759A Withdrawn JP2020532513A (ja) 2017-09-05 2018-09-04 トリアミノピリミジン化合物およびその中間体の調製方法

Country Status (10)

Country Link
US (1) US12378223B2 (enExample)
EP (1) EP3679030B1 (enExample)
JP (1) JP2020532513A (enExample)
CN (1) CN111051299A (enExample)
CA (1) CA3071226A1 (enExample)
ES (1) ES2979379T3 (enExample)
MX (2) MX2020002142A (enExample)
PH (1) PH12020500385A1 (enExample)
WO (1) WO2019049021A1 (enExample)
ZA (1) ZA202000903B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025115034A1 (en) * 2023-11-30 2025-06-05 Zydus Lifesciences Limited A process for the preparation of a triaminopyrimidine compound and novel intermediates thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS58124B1 (sr) * 2014-04-28 2019-02-28 Medicines For Malaria Venture Mmv Triaminopirimidin jedinjenja korisna za prevenciju ili tretman malarije

Similar Documents

Publication Publication Date Title
CA2694242C (en) Process for introduction of hydroxyethoxy side chain in bosentan
JP2009537603A (ja) 5−アミノ−3−(2’,3’−ジ−O−アセチル−ベータ−D−リボフラノシル)−3H−チアゾロ[4,5−d]ピリミジン−2−オンのマレイン酸塩のA型及びB型結晶形
US8686153B2 (en) Lenalidomide salts
US10807978B2 (en) Process for preparation of palbociclib
WO2016178150A1 (en) Novel polymorphs of axitinib
US10870654B2 (en) Pharmaceutically acceptable salts and polymorphic forms of hydrocodone benzoic acid enol ester and processes for making same
US11230559B2 (en) Solid forms of [(1 S)-1 -[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-D]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-Yl]proptl] acetate
EP3042893B1 (en) Novel crystalline arylalkylamine compound and method for producing same
KR100878698B1 (ko) 결정형의 베포타스틴 금속염 수화물, 이의 제조방법 및이를 포함하는 약학 조성물
WO2013179105A1 (en) Improved process for preparation of rilpivirine and pharmaceutically acceptable salts thereof
US9150524B2 (en) Pure intermediate
US12012421B2 (en) Solid forms of [(1S)-1-[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-d]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-yl]propyl] acetate
WO2017021904A1 (en) Daclatasvir free base and process for the preparation thereof
KR101307712B1 (ko) 결정형의 베포타스틴 금속염 수화물, 이의 제조방법 및 이를 포함하는 약학 조성물
JP6663232B2 (ja) 新規結晶構造を有するアジルサルタン及びその製造方法
CA3048771C (en) Solid forms of [(1s)-1-[(2s,4r,5r)-5-(5-amino-2-oxo-thiazolo[4,5-d]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-yl]propyl] acetate
EP3679030A1 (en) A process for preparation of triaminopyrimidine compound and intermediates thereof
RU2021123182A (ru) Кристаллические формы (s)-2-(7-циано-1h-бензимидазол-1-ил)-n-{ 1-[4-(1-циано-1-метилэтил)фенил]этил} ацетамида
US20080262009A1 (en) Crystalline polymorphs of n-(3-(dimethylamino)propyl)-4-(4-(3-fluoro-4-methoxyphenyl) pyrimidin-2-ylamino) benzenesulfonamide as acetate salts
KR20130033243A (ko) 아데포비어 디피복실의 공결정
HK1210080B (zh) 5-羟基-1h-咪唑-4-甲酰胺的硫酸盐
US20140228383A1 (en) Process for the production of moxonidine
HK1223928B (en) Novel crystalline arylalkylamine compound and method for producing same